-
Je něco špatně v tomto záznamu ?
A review of national guidelines for management of COPD in Europe
M. Miravitlles, C. Vogelmeier, N. Roche, D. Halpin, J. Cardoso, AG. Chuchalin, H. Kankaanranta, T. Sandström, P. Śliwiński, J. Zatloukal, F. Blasi,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
NLK
Free Medical Journals
od 1994 do Před 18 měsíci
Open Access Digital Library
od 1988-01-01
- MeSH
- bronchodilatancia terapeutické užití MeSH
- chronická obstrukční plicní nemoc diagnóza farmakoterapie MeSH
- expektorancia terapeutické užití MeSH
- hormony kůry nadledvin terapeutické užití MeSH
- lidé MeSH
- management nemoci MeSH
- medicína založená na důkazech MeSH
- plánování péče o pacienty MeSH
- směrnice pro lékařskou praxi jako téma * MeSH
- výběr pacientů MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
- Geografické názvy
- Anglie MeSH
- Česká republika MeSH
- Evropa MeSH
- Finsko MeSH
- Francie MeSH
- Itálie MeSH
- Německo MeSH
- Polsko MeSH
- Portugalsko MeSH
- Rusko MeSH
- Španělsko MeSH
- Švédsko MeSH
- Wales MeSH
The quality of care can be improved by the development and implementation of evidence-based treatment guidelines. Different national guidelines for chronic obstructive pulmonary disease (COPD) exist in Europe and relevant differences may exist among them.This was an evaluation of COPD treatment guidelines published in Europe and Russia in the past 7 years. Each guideline was reviewed in detail and information about the most important aspects of patient diagnosis, risk stratification and pharmacotherapy was extracted following a standardised process. Guidelines were available from the Czech Republic, England and Wales, Finland, France, Germany, Italy, Poland, Portugal, Russia, Spain and Sweden. The treatment goals, criteria for COPD diagnosis, consideration of comorbidities in treatment selection and support for use of long-acting bronchodilators, were similar across treatment guidelines. There were differences in measures used for stratification of disease severity, consideration of patient phenotypes, criteria for the use of inhaled corticosteroids and recommendations for other medications (e.g. theophylline and mucolytics) in addition to bronchodilators.There is generally good agreement on treatment goals, criteria for diagnosis of COPD and use of long-acting bronchodilators as the cornerstone of treatment among guidelines for COPD management in Europe and Russia. However, there are differences in the definitions of patient subgroups and other recommended treatments.
2nd Department of Respiratory Medicine Institute of Tuberculosis and Lung Diseases Warsaw Poland
Department of Public Health and Clinical Medicine Medicine Unit Umeå University Umeå Sweden
Dept of Respiratory Medicine University Hospital Olomouc Olomouc Czech Republic
Institute of Pulmonology Federal Medical and Biological Agency Moscow Russia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17000601
- 003
- CZ-PrNML
- 005
- 20170117122655.0
- 007
- ta
- 008
- 170103s2016 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1183/13993003.01170-2015 $2 doi
- 024 7_
- $a 10.1183/13993003.01170-2015 $2 doi
- 035 __
- $a (PubMed)26797035
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Miravitlles, Marc $u Pneumology Dept, University Hospital Vall d'Hebron, Ciber de Enfermedades Respiratorias (CIBERES), Barcelona, Spain mmiravitlles@vhebron.net.
- 245 12
- $a A review of national guidelines for management of COPD in Europe / $c M. Miravitlles, C. Vogelmeier, N. Roche, D. Halpin, J. Cardoso, AG. Chuchalin, H. Kankaanranta, T. Sandström, P. Śliwiński, J. Zatloukal, F. Blasi,
- 520 9_
- $a The quality of care can be improved by the development and implementation of evidence-based treatment guidelines. Different national guidelines for chronic obstructive pulmonary disease (COPD) exist in Europe and relevant differences may exist among them.This was an evaluation of COPD treatment guidelines published in Europe and Russia in the past 7 years. Each guideline was reviewed in detail and information about the most important aspects of patient diagnosis, risk stratification and pharmacotherapy was extracted following a standardised process. Guidelines were available from the Czech Republic, England and Wales, Finland, France, Germany, Italy, Poland, Portugal, Russia, Spain and Sweden. The treatment goals, criteria for COPD diagnosis, consideration of comorbidities in treatment selection and support for use of long-acting bronchodilators, were similar across treatment guidelines. There were differences in measures used for stratification of disease severity, consideration of patient phenotypes, criteria for the use of inhaled corticosteroids and recommendations for other medications (e.g. theophylline and mucolytics) in addition to bronchodilators.There is generally good agreement on treatment goals, criteria for diagnosis of COPD and use of long-acting bronchodilators as the cornerstone of treatment among guidelines for COPD management in Europe and Russia. However, there are differences in the definitions of patient subgroups and other recommended treatments.
- 650 _2
- $a hormony kůry nadledvin $x terapeutické užití $7 D000305
- 650 _2
- $a bronchodilatancia $x terapeutické užití $7 D001993
- 650 _2
- $a Česká republika $7 D018153
- 650 _2
- $a management nemoci $7 D019468
- 650 _2
- $a Anglie $7 D004739
- 650 _2
- $a Evropa $7 D005060
- 650 _2
- $a medicína založená na důkazech $7 D019317
- 650 _2
- $a expektorancia $x terapeutické užití $7 D005100
- 650 _2
- $a Finsko $7 D005387
- 650 _2
- $a Francie $7 D005602
- 650 _2
- $a Německo $7 D005858
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a Itálie $7 D007558
- 650 _2
- $a plánování péče o pacienty $7 D010347
- 650 _2
- $a výběr pacientů $7 D018579
- 650 _2
- $a Polsko $7 D011044
- 650 _2
- $a Portugalsko $7 D011174
- 650 12
- $a směrnice pro lékařskou praxi jako téma $7 D017410
- 650 _2
- $a chronická obstrukční plicní nemoc $x diagnóza $x farmakoterapie $7 D029424
- 650 _2
- $a Rusko $7 D012426
- 650 _2
- $a Španělsko $7 D013030
- 650 _2
- $a Švédsko $7 D013548
- 650 _2
- $a Wales $7 D014852
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Vogelmeier, Claus $u Dept of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-University Marburg, German Center for Lung Research (DZL), Marburg, Germany.
- 700 1_
- $a Roche, Nicolas $u Service de Pneumologie et Soins Intensifs Respiratoires, Hôpital Cochin, University Paris Descartes (EA2511), Paris, France.
- 700 1_
- $a Halpin, David $u Royal Devon and Exeter Hospital, Exeter, UK.
- 700 1_
- $a Cardoso, João $u Hospital de Santa Marta, Centro Hospitalar de Lisboa Central, Universidade Nova de Lisboa, Lisbon, Portugal.
- 700 1_
- $a Chuchalin, Alexander G $u Institute of Pulmonology, Federal Medical and Biological Agency, Moscow, Russia.
- 700 1_
- $a Kankaanranta, Hannu $u Dept of Respiratory Medicine, Seinäjoki Central Hospital, Seinäjoki, Finland Dept of Respiratory Medicine, University of Tampere, Tampere, Finland.
- 700 1_
- $a Sandström, Thomas $u Department of Public Health and Clinical Medicine, Medicine Unit, Umeå University, Umeå, Sweden.
- 700 1_
- $a Śliwiński, Paweł $u 2nd Department of Respiratory Medicine, Institute of Tuberculosis and Lung Diseases, Warsaw, Poland.
- 700 1_
- $a Zatloukal, Jaromir $u Dept of Respiratory Medicine, University Hospital Olomouc, Olomouc, Czech Republic.
- 700 1_
- $a Blasi, Francesco $u Dept of Pathophysiology and Transplantation, Università degli Studi di Milano, IRCCS Fondazione Ospedale Maggiore Policlinico Cà Granda, Milan, Italy.
- 773 0_
- $w MED00001660 $t The European respiratory journal $x 1399-3003 $g Roč. 47, č. 2 (2016), s. 625-37
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26797035 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170103 $b ABA008
- 991 __
- $a 20170117122801 $b ABA008
- 999 __
- $a ok $b bmc $g 1179741 $s 961168
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 47 $c 2 $d 625-37 $e 20160121 $i 1399-3003 $m The European respiratory journal $n Eur Respir J $x MED00001660
- LZP __
- $a Pubmed-20170103